BIOPHARMA CREDIT PLC

Report Publication Announcement • Aug 18, 2020

National Storage Mechanism | Additional information

RNS Number : 4919W

BioPharma Credit PLC

18 August 2020

18 August 2020

BIOPHARMA CREDIT PLC

(The "Company") 

NOTICE OF HALF YEAR RESULTS

BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its Half Year Results for the period ended 30 June 2020 on Wednesday 16 September 2020.

A management presentation for analysts will be delivered at 2pm BST on the day of the results through a conference call facility.

To request conference call details, RSVP to biopharmacredit@buchanan.uk.com.

-Ends-

Enquiries

BioPharma Credit PLC

via Link Company Matters Limited

Company Secretary

+44 (0) 1392 477 500

Buchanan

+44 (0)20 7466 5000

David Rydell / Mark Court / Jamie Hooper / Henry Wilson

biopharmacredit@buchanan.uk.com

Notes to Editors:

BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.

LEI: 213800AV55PYXAS7SY24

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORGPUPGRUPUGCR